Reviva Pharmaceuticals (RVPH) Earnings Date and Reports 2024

Reviva Pharmaceuticals announced Q2 2024 earnings on August 14, 2024, reporting an EPS of -$0.26, which beat the consensus estimate of -$0.28 by $0.02. With a trailing EPS of -$1.30, Reviva Pharmaceuticals' earnings are expected to grow next year, from ($0.98) to ($0.81) per …

CouponFollow Extension

$0.26
OFF

Reviva Pharmaceuticals (RVPH) Earnings Date And Reports 2024

1 week from now

marketbeat.com

$8
OFF

Reviva Reports Third Quarter 2024 Financial Results And Recent

1 week from now

3 days ago · Anticipated Milestones and Events. Third Quarter 2024 Financial Results. The Company reported a net loss of approximately $8.4 million, or $0.25 per share, for the three months ended September 30 ...

nasdaq.com

$3
OFF

Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Stock Analysis

1 week from now

Reviva Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules. CUPERTINO, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek... 5 months ago - GlobeNewsWire.

stockanalysis.com

$8
OFF

Reviva Reports Third Quarter 2024 Financial Results And

1 week from now

4 days ago · Corporate Highlights. Anticipated Milestones and Events. Third Quarter 2024 Financial Results. The Company reported a net loss of approximately $8.4 million, or $0.25 per share, for the three ...

morningstar.com

$8
OFF

Reviva Reports Third Quarter 2024 Financial Results And Recent …

1 week from now

3 days ago · Pursue partnership opportunities for the development of our pipeline. Third Quarter 2024 Financial Results. The Company reported a net loss of approximately $8.4 million, or $0.25 per share, for the three months ended September 30, 2024, compared to a net loss of approximately $11.3 million, or $0.48 per share, for the same period in 2023 (as ...

marketscreener.com

50%
OFF

Reviva Pharmaceuticals Holdings Earnings Dates, Reports, Calls …

1 week from now

On RVPH's earnings call on Invalid Date, . Reviva Pharmaceuticals Holdings (NASDAQ: RVPH) reported Q2 2024 earnings per share (EPS) of -$0.26, up 50% year over year. Total RVPH earnings for the quarter were -$7.86 million.In the same quarter last year, Reviva Pharmaceuticals Holdings's earnings per share (EPS) was -$0.52.

wallstreetzen.com

0%
OFF

RVPH Earnings Dates, Upcoming And Historical (Reviva...)

1 week from now

Following its earnings release, 86 days ago, RVPH stock has drifted +31.0% higher. From the time it announced earnings, RVPH traded in a range between 0.60 and 1.57. The last price (0.94) is closer to the lower end of range. Next RVPH Earnings Date: RVPH is estimated to announce earnings between November 12, 2024 and November 14, 2024 (the ...

marketchameleon.com

$8
OFF

Reviva Pharmaceuticals Holdings Inc Reports Q3 2024 GAAP EPS …

1 week from now

Summary. Net Loss: Reported a net loss of approximately $8.4 million for Q3 2024, an improvement from the $11.3 million loss in Q3 2023. Earnings Per Share (EPS): GAAP EPS was -$0.25, showing improvement from -$0.48 in the same quarter last year. Cash Position: Cash reserves stood at approximately $5.6 million as of September 30, 2024, down ...

gurufocus.com

$8
OFF

Reviva Reports Third Quarter 2024 Financial Results And

1 week from now

3 days ago · Corporate Highlights. Anticipated Milestones and Events. Third Quarter 2024 Financial Results. The Company reported a net loss of approximately $8.4 million, or $0.25 per share, for the three ...

globenewswire.com

FAQs about Reviva Pharmaceuticals (RVPH) Earnings Date and Reports 2024 Coupon?

When will Reviva Pharmaceuticals (rvph) earnings release?

Reviva Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 21st, 2023 based off last year's report dates. Learn more on RVPH's earnings history. ...

When is Reviva Pharmaceuticals's next earnings date?

Reviva Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 21st, 2023 based off prior year's report dates. When is Reviva Pharmaceuticals's earnings date? ...

Who controls Reviva Pharmaceuticals holdings (rvph)?

If you want to know who really controls Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH), then you'll have to look at the makeup of its share registry. The group holding the most number of shares in the company, around 25% to be precise, is individual investors. ...

Should I buy Reviva Pharmaceuticals (RVPH) stock?

According to 4 Wall Street research analysts, investors should 'buy' Reviva Pharmaceuticals (RVPH) shares. There are currently 4 buy ratings for the stock, and it is the consensus among analysts. ...

Who owns Reviva Pharmaceuticals holdings?

The general public, who are usually individual investors, hold a 25% stake in Reviva Pharmaceuticals Holdings. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies. Private Equity Ownership ...

What does Reviva Pharmaceuticals do?

Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. ...